| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/01/2006 | US7083965 Polypeptides, polynucleotides; hybrids; culture product |
| 08/01/2006 | US7083957 Modified proteins, designer toxins, and methods of making thereof |
| 08/01/2006 | US7083937 Characterizing purity and activity of polysaccharide preparations including glycosaminoglycans such as heparin |
| 08/01/2006 | CA2277990C 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/01/2006 | CA2198701C Substituted 9-alkyladenines |
| 07/27/2006 | WO2006078621A2 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 07/27/2006 | WO2006078257A1 Substituted fullerene compositions and their use in treatment of shock |
| 07/27/2006 | WO2006077851A1 Quinolone derivative and salt thereof |
| 07/27/2006 | WO2006077386A1 Composition and device comprising an inorganic component (metal compound) for coagulation of protein-containing fluids |
| 07/27/2006 | WO2006044582A3 Use of baff to treat sepsis |
| 07/27/2006 | US20060168672 B7-like molecules and uses thereof |
| 07/27/2006 | US20060167402 Method and composition for inhibiting cardiovascular cell proliferation |
| 07/27/2006 | US20060167267 Michael-type addition of a nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and the conversion of a ester moiety into an amino moiety; S)-2-methylcysteine; desferrithiocin |
| 07/27/2006 | US20060167261 e.g. N-(4-Chloro-3-trifluoro methyl phenyl)-2-[3-(4-pyridinyloxy)phenyl amino]-acetamide; serine/threonine kinase inhibitor; anticarcinogenic, antiproliferative, antidiabetic agent; autoimmune diseases; atherosclerosis, arthritis, Crohn's disease, retinopaty |
| 07/27/2006 | US20060167230 Anti-pci neutralizing antibody |
| 07/27/2006 | US20060167100 Orodispersible pharmaceutical composition of an antithrombotic compound |
| 07/27/2006 | US20060167059 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 07/27/2006 | US20060167048 N-4-piperidinyl compounds as ccr5 modulators |
| 07/27/2006 | US20060167036 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 07/27/2006 | US20060166999 Use of microsomal triglyceride transfer protein (MTP) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (PPTRL) |
| 07/27/2006 | US20060166989 2-naphthamide derivatives |
| 07/27/2006 | US20060166940 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases |
| 07/27/2006 | US20060166255 Methods of using 48149, a human Aminopeptidase family member |
| 07/27/2006 | US20060165721 Cinnamomi and poria composition, method to prepare same and uses thereof |
| 07/27/2006 | US20060165694 Fab fragments and their DNA sequences used for preparation of complete recombinant Anti-Rhesus D antibodies; biodrugs; medical diagnosis |
| 07/27/2006 | CA2601328A1 Composition and device comprising an inorganic component (metal compound) for coagulation of protein-containing fluids |
| 07/26/2006 | EP1682530A1 Substituted pyrrole-indoles as inhibitors of pai-1 |
| 07/26/2006 | EP1682167A1 Use of hyperpolymer haemoglobin for treating a pulmonary oedema |
| 07/26/2006 | EP1527063B1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 07/26/2006 | EP1390543B1 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 07/26/2006 | EP1381686B1 Inactivation of genes of the mep pathway |
| 07/26/2006 | EP1240313B1 Homologue enzymes of human heparanase and splice variants thereof |
| 07/26/2006 | EP0934424B1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium |
| 07/26/2006 | CN2798942Y Aspirin dipyridamole slow-release tablet |
| 07/26/2006 | CN1809570A [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 07/26/2006 | CN1809346A Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor XA and VIIA inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then |
| 07/26/2006 | CN1806839A Preparation method of dragon's blood abnormity tablet and dragon's blood abnormity coating tablet |
| 07/26/2006 | CN1266134C Fused-polycyclic compounds |
| 07/26/2006 | CN1265814C Tanacetum parthenium extract |
| 07/25/2006 | US7081523 And stimulate erythropoiesis; teatment of anemia |
| 07/25/2006 | US7081468 Angiogenesis inhibitors; antitumor agents; skin disorders; antiarthritic agents |
| 07/25/2006 | US7081460 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/25/2006 | CA2206423C Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 07/20/2006 | WO2006075523A1 Blood cholesterol reducing oral composition |
| 07/20/2006 | WO2006075336A1 An herbal composition for treatment for blood and heart /skin related diseases and process of preparing thereof |
| 07/20/2006 | WO2006074918A1 Agents containing folic acid, vitamin b6 and vitamin b12, and the use thereof |
| 07/20/2006 | WO2003101177A3 Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions |
| 07/20/2006 | US20060161004 Quinoline derivatives for therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper-reactivity, cough, inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 07/20/2006 | US20060160886 Chemical compounds |
| 07/20/2006 | US20060160885 Chemical compounds |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160816 Pirazino(AZA) indole derivatives |
| 07/20/2006 | US20060160768 Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 07/20/2006 | US20060160132 Diagnositics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 07/20/2006 | US20060160083 Diagnositics and therapeutics for diseases associated with human g-protein couple receptor 14 (gpr14) |
| 07/20/2006 | US20060159719 Method and composition for inhibiting cardiovascular cell proliferation |
| 07/20/2006 | CA2594775A1 Agents containing folic acid, vitamin b6 and vitamin b12, and the use thereof |
| 07/19/2006 | EP1681355A1 Sequence-specific DNA recombination in eukaryotic cells |
| 07/19/2006 | EP1681348A1 MU-1 member of the cytokine receptor family |
| 07/19/2006 | EP1681305A2 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 07/19/2006 | EP1681051A1 Multi-layer controlled-release tablet comprising an active layer and one or more barrier layers |
| 07/19/2006 | EP1680963A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/19/2006 | EP1680107A1 Substituted oxadiazolidinediones als pai-1 inhibitors |
| 07/19/2006 | EP1483284B1 Selective dipeptide inhibitors of kallikrein |
| 07/19/2006 | EP1389137B1 Compositions for protein delivery via the pulmonary route |
| 07/19/2006 | EP1379695B1 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 07/19/2006 | EP1370556B1 Metalloproteinase inhibitors |
| 07/19/2006 | EP1301507B1 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 07/19/2006 | EP1294721B1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/19/2006 | CN1804032A Novel earthworm fibrinolytic enzyme, its encoding sequence and uses |
| 07/19/2006 | CN1803184A Compound dragon's blood medicine |
| 07/19/2006 | CN1803176A Use of aloe in preparing blood plasma substitute and aloe juice substitute for blood plasma |
| 07/19/2006 | CN1803149A Traditional Chinese medicine deer blood crystal and its preparation method |
| 07/19/2006 | CN1802976A Canton love-pea vine healthcare tea and its preparation method |
| 07/19/2006 | CN1264856C Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 07/19/2006 | CN1264842C Method for producing by stereospecific hydration tetrahydropterins and optical pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives |
| 07/19/2006 | CN1264819C Process for stereo selective synthesis of prostacyclin derivatives |
| 07/19/2006 | CN1264578C Carrier with solid fibrinogen and solid thrombin |
| 07/19/2006 | CN1264558C Chinese medicinal composition for treating internal hemorrhage |
| 07/19/2006 | CN1264522C Medicinal composition, its preparation method and its use |
| 07/19/2006 | CN1264516C Ligustrazine phosphate dripping pill and preparation thereof |
| 07/18/2006 | US7078565 Benzamide derivatives as antagonists of orexin receptors |
| 07/18/2006 | US7078558 Salt formated crystal for treating hypercholesterolemia and hyperlipidemia; anticholesterol agents, antilipemic agents |
| 07/18/2006 | US7078508 Anticoagulant; Dna immobilized on substrate; binding to antibody |
| 07/18/2006 | US7078420 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 07/18/2006 | US7078415 1-(omego-substituted-2-[(hetero)arylcarbonylamino]alkanoyl)-4-(1-methylpiperidin-4-yl)piperidine derivatives; e.g., 1-[N-(Indole-6-carbonyl)-D-serinyl]-4-(1-methylpiperidin-4-yl)piperidine Hydrochloride |
| 07/18/2006 | US7078414 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
| 07/18/2006 | US7078400 20-hydroxyeicosatetraenoic acid (HETE); useful as therapeutic agents for kidney diseases, cerebrovascular diseases, or circulatory diseases |
| 07/18/2006 | US7078230 Adipose tissue-derived stromal cell that expresses characteristics of a neuronal cell |
| 07/18/2006 | US7078217 Aggrecanase molecules |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/13/2006 | WO2006073361A1 Novel pyridine compounds |
| 07/13/2006 | WO2006073197A1 1-thio-d-glucitol derivatives |
| 07/13/2006 | WO2006073167A1 Pyrrolidine derivatives |
| 07/13/2006 | WO2006073164A1 Dialysis preparation |
| 07/13/2006 | WO2006073119A1 Polypeptide and use of the same |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072353A1 Azetidine-substituted pyrazolines as par-1 antagonists |
| 07/13/2006 | WO2006072351A1 Heteroaryl-substituited pyrazolines as par-1 antagonists |
| 07/13/2006 | WO2006072349A1 Thiophene-substituited pyrazolines |